IRIS
FILIPPI, ANDREA RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.327
AS - Asia 1.995
EU - Europa 1.372
SA - Sud America 305
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 139
OC - Oceania 3
Totale 7.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.224
SG - Singapore 649
IE - Irlanda 556
CN - Cina 513
HK - Hong Kong 295
VN - Vietnam 239
BR - Brasile 219
RU - Federazione Russa 204
FR - Francia 122
ZA - Sudafrica 119
IT - Italia 115
DE - Germania 113
IN - India 76
FI - Finlandia 71
BD - Bangladesh 65
CA - Canada 57
GB - Regno Unito 38
SE - Svezia 31
CZ - Repubblica Ceca 28
IQ - Iraq 28
AR - Argentina 26
MX - Messico 23
TR - Turchia 21
JP - Giappone 20
NL - Olanda 17
CO - Colombia 15
EC - Ecuador 15
PK - Pakistan 15
BE - Belgio 12
SA - Arabia Saudita 12
PL - Polonia 11
AT - Austria 10
CL - Cile 10
ID - Indonesia 10
MA - Marocco 10
ES - Italia 9
KE - Kenya 9
LT - Lituania 8
PH - Filippine 8
VE - Venezuela 7
HN - Honduras 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
PA - Panama 5
UZ - Uzbekistan 5
JO - Giordania 4
MY - Malesia 4
PE - Perù 4
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
HU - Ungheria 3
JM - Giamaica 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GN - Guinea 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MU - Mauritius 1
NC - Nuova Caledonia 1
OM - Oman 1
SO - Somalia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 7.157
Salva come PNG Salva come JPEG
Città #
Dublin 555
Ashburn 488
San Jose 452
Chandler 334
Hong Kong 288
Singapore 283
Dallas 178
Beijing 163
Council Bluffs 150
Boardman 122
Princeton 116
Johannesburg 111
Lauterbourg 100
Lawrence 98
Ho Chi Minh City 90
Medford 80
Los Angeles 67
Wilmington 65
Shanghai 64
Hanoi 50
Washington 50
Santa Clara 48
Buffalo 47
Helsinki 45
Munich 44
Redondo Beach 44
New York 36
Toronto 27
Moscow 25
Turku 25
São Paulo 23
Brno 22
Pavia 22
Chicago 19
Norwalk 18
Nuremberg 17
Ann Arbor 16
Columbus 16
Tokyo 16
Milan 15
Stockholm 15
London 14
Orem 14
Frankfurt am Main 13
The Dalles 13
Chennai 12
Brussels 11
Dhaka 11
Guangzhou 11
Haiphong 11
Brooklyn 10
Falkenstein 10
New Delhi 10
Saint Louis 10
Atlanta 9
Baghdad 9
Mexico City 9
Montreal 9
Nairobi 9
Rio de Janeiro 9
Ankara 8
Düsseldorf 8
Phoenix 8
Seattle 8
Amsterdam 7
Boston 7
Denver 7
Houston 7
Vienna 7
Warsaw 7
Zhengzhou 7
Belo Horizonte 6
Da Nang 6
Erbil 6
Guayaquil 6
Lahore 6
Pune 6
Redwood City 6
Baku 5
Canyon Country 5
Jakarta 5
Jeddah 5
Olomouc 5
Casablanca 4
Changsha 4
Charlotte 4
Chengdu 4
Curitiba 4
Dong Ket 4
Goiânia 4
Hangzhou 4
Ludhiana 4
Memphis 4
Ottawa 4
Portsmouth 4
Riyadh 4
Rome 4
Shenzhen 4
Tashkent 4
Tianjin 4
Totale 4.864
Salva come PNG Salva come JPEG
Nome #
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 127
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study 124
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 122
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 114
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 110
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 108
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 106
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 104
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 101
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 100
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 99
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 98
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG 97
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 96
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 96
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 95
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 93
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiation therapy 91
The prognostic impact of BIA-derived fat-free mass index in patients with cancer 90
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 87
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 83
Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: Cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs 81
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 81
COVID-19 OUTBREAK IN NORTHERN ITALY: FIRST PRACTICAL INDICATIONS FOR RADIOTHERAPY DEPARTMENTS 80
To a new normal in radiation oncology: looking back and planning forward 80
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 80
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 79
Definitive radiotherapy for localized follicular lymphoma staged by18F-FDG PET-CT: A collaborative study by ILROG 76
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 75
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 75
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 73
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 73
Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach 72
COVID-19: Global radiation oncology's targeted response for pandemic preparedness 72
Radiomics features as predictive and prognostic biomarkers in NSCLC 72
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 72
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations 71
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 70
Brain metastases from lung cancer: Is MET an actionable target? 70
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 70
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 69
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy 68
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 67
Radiomics features as predictive and prognostic biomarkers in NSCLC 67
A Strategy for Young Members within National Radiation Oncology Societies: the Italian Experience (AIRO Giovani Group) 67
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 67
Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy 66
Is clinical radiosensitivity a complex genetically controlled event? 65
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 65
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA 65
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 64
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia 64
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 62
Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma 62
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start? 61
A young boy with ventricular arrhythmias and thyroid dysgenesis: two genes are not enough? 60
Radiotherapy in Pediatric Oncology 60
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation 60
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 59
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy 59
Extranodal Marginal Zone Lymphoma 59
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study 59
Treatment of metastatic melanoma: a multidisciplinary approach 59
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group 55
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins 54
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 54
Current role and future developments of radiotherapy in Hodgkin's lymphoma 54
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease 53
Stereotactic radiotherapy for early stage non-small cell lung cancer 53
Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study 52
Radiation therapy for older patients with brain tumors 52
Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) 52
Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy 51
Large cohort observational study integrates current knowledge on changes in outcome for melanoma brain metastases in tyrosine kinase inhibitor (TKI)-immunotherapy era 50
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: a systematic review 50
The "BUONGIORNO" Project: Burnout Syndrome Among Young Italian Radiation Oncologists 49
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients 49
Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer 49
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 49
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 48
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial 48
Emo-linfopatie maligne 48
Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation 48
Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma 48
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 48
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases 48
Limited stage follicular lymphoma: Current role of radiation therapy 47
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 45
New concepts and insights into the role of radiation therapy in extracranial metastatic disease 45
Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk 45
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 45
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 45
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists 44
Stereotactic body radiation therapy for lung metastases 44
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 44
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 43
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience 43
Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies 42
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial 42
Innovative technologies in thoracic radiation therapy for lung cancer 42
Totale 6.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022398 0 0 19 6 7 9 9 29 23 9 68 219
2022/20231.153 134 49 5 68 70 98 3 67 618 4 32 5
2023/2024617 59 67 71 37 73 193 56 12 0 23 1 25
2024/20251.337 43 121 34 47 19 60 46 53 367 73 124 350
2025/20263.221 217 228 273 309 372 129 631 211 341 231 169 110
2026/2027311 103 182 26 0 0 0 0 0 0 0 0 0
Totale 7.293